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Objective: To investigate the functional recovery following 
the transplantation of human embryonic stem (hES) cells 
into an injured rat spinal cord. 
Method: Sprague-Dawley rats were subjected to the spinal 
cord injury (SCI) using the New York University impactor. 
The rats were randomly allocated into three groups of 12 
rats each, one media-treated and two hES cell-transplanted 
groups (5×103/5μl, 2×104/5μl). The hES cells were 
transplanted 1 week after a SCI. 
Results: The hES cells transplanted into the rats were found 
to promote the hind limb performance 8 weeks after trans-
plantation. In the electrophysiological study, the transplanted 
rats showed significantly shortened latencies and increased 
amplitudes of motor and somatosensory evoked potentials, 
compared to the media-treated rats. In the spinal cord of the 
hES cell-treated group, the pathological findings including 
the glial scar formation and degenerative changes were 
attenuated and the human Tau protein-positive cells were 
identified in the vicinity of the necrotic cavity and in the 
white matter. 
Conclusion: These results suggest that the transplantation of 
hES cells might play a role in promoting the functional 
recovery after a SCI. (J Korean Acad Rehab Med 2008; 
32: 491-500)
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INTRODUCTION
Recovery from spinal cord injury (SCI) is quite difficult 
owing to the limited ability of the vertebrate central nervous 
system to regenerate injured cells, replace damaged myelin 
sheath and re-establish functional neuronal connections. So 
many patients with SCI, who are tetraplegics or paraplegics, 
have difficulty in walking and cannot help being dependent to 
accomplish the activities of daily living for their remaining 
years.
Recently, as a therapeutic approach in SCI, stem cells 
provide a partial solution for the treatment of SCI because they 
are genetically normal, multipotential and capable of indefinite 
replication. In 1999, Brustle et al.1 reported that transplantation 
in a rat model of a human myelin disease showed that 
embryonic stem cell-derived glial precursors interacted with 
host neurons and efficiently myelinated axons in spinal cord. 
Similarly, Akiyama et al.2 examined the myelin repairing 
potential of transplanted neural precursor cells derived from the 
adult human brain from tissue removed during surgery. They 
also suggested that transplantation of these cells into the 
demyelinated rat spinal cord resulted in extensive remyelination 
and the remyelinated axons conducted impulses at near normal 
conduction velocity. McDonald et al.3 transplanted neural 
differentiated mouse embryonic stem cells into a rat spinal cord 
after traumatic injury. They reported that 2∼5 weeks later, 
transplanted cells survived and differentiated into astrocytes, 
oligodendrocytes and neurons, furthermore transplanted rats 
showed hindlimb weight support and partial hindlimb coordi-
nation.
Human embryonic stem (hES) cells derived from the inner 
cell mass of blastocyst-stage embryos are more totipotent.4,5 
These hES cells have a remarkable proliferative capacity and 
stability in a long-term culture6 and can differentiate into various 
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types of cells including hematopoietic precursors, heart and 
skeletal muscle, endothelium, and neural cells.4,5 Therefore, hES 
cells may be a potential source for cell therapy in a central 
nervous system with different type of injuries.
This study was carried out to investigate whether hES cells 
could regenerate to replace lost neuronal cells, remyelinate the 
damaged axons and restore the function of injured rat spinal cord.
MATERIALS & METHODS
1) The establishment of an animal model
Male adult Sprague-Dawley rats (Daehan Biolink Co., Eum-
seong, Korea) weighted 300∼350 g at the time of surgery were 
used in this study. The animals were housed in a facility fully 
accredited by the Association for Assessment and Accreditation 
of Laboratory Animal Care (AAALAC). The temperature and 
humidity were kept constant at 22±2°C and 50±10%, respec-
tively. Food and water were available ad libitum. The In-
stitutional Review Board in Yonsei University approved all the 
experimental procedures and the NIH guidelines were followed.
An acute incomplete spinal cord injury was induced using 
the New York University (NYU) weight-drop device. The rats 
were anesthetized with 50 mg/kg pentobarbital (Sigma, Saint 
Louis, USA) given by intraperitoneal injection and a laminec-
tomy was performed at the T9 spinal level. The exposed dorsal 
surface of the cord was then subjected to a weight-drop impact. 
The moderately contused incomplete SCI models were obtained 
by dropping a 10 g weight impact rod from a 25 mm height. 
The contusion impact velocity and compression rate were 
monitored in order to guarantee the consistency between 
animals. During their recovery, rectal temperatures were 
maintained at 37°C by a feedback-regulated heating pad. The 
postoperative nursing care included a bladder expression twice 
a day. Prophylactic 1 mg/kg gentamycin sulfate (Sigma, Saint 
Louis, USA) was regularly administered for a week.
2) Behavioral assessment after SCI
A behavioral test was performed to measure the functional 
recovery of the hindlimbs of the rats. The open field testing 
procedure previously described by Basso et al.7 was used. The 
rats were gently adapted to the open field which was a 
molded-plastic circular enclosure with a smooth, nonslip floor 
(90 cm diameter; 21 cm wall height). Once a rat walked 
continuously in the open field, three investigators conducted the 
5 minute testing sessions on each leg. The open field test was 
performed on all the animals at least once a week from day 
1 to 9 weeks after surgery.
3) Culture of hES cells 
The hES cells (SNU-hES3: Korea Stem Cell Research 
Center registered cell line) were maintained in Dulbecco's 
modified Eagle's medium (DMEM, Life Technologies, Bochum, 
Germany) supplemented with 20% (v/v) serum replacements 
(Life Technologies, Bochum, Germany), 100 IU/ml penicillin 
(Life Technologies, Bochum, Germany), 100 g/ml streptomycin 
(Life Technologies, Bochum, Germany), 0.1 mM nonessential 
amino acids (Life Technologies, Bochum, Germany), 0.1 mM 
mercaptoethanol (Sigma, Saint Louis, USA) and 4 ng/ml basic 
fibroblast growth factor (bFGF, Dong-A Pharmaceutical Co., 
Yongin, Korea). The hES cell colonies were cultured on a 
feeder layer of SIM mouse embryo-derived thioguanine and 
ouabain resistant (STO) cells pre-treated with mitomycin C 
(Sigma, Saint Louis, USA). The hES cell colonies were isolated 
mechanically and dissociated to single cells using trypsin- 
EDTA 1X (Life Technologies, Bochum, Germany) prior to 
transplantation.
4) Transplantation of hES cells 
After the behavioral test was performed for 1 week after the 
SCI, the rats were assigned, without bias, into three groups of 
12 rats each (one media-treated and two hES cell-transplanted 
groups) and were anesthetized with halothane (1：2, N2O：O2) 
(Sigma, Saint Louis, USA). Using a capillary glass tube, 5μl 
of cultured hES (5×103 or 2×104) cells was transplanted into 
the epicenter of the injury in two transplantation groups. In a 
preliminary study, 5×104 hES cells were transplanted into 
injured rat spinal cord. It showed that the transplanted hES cells 
led to formation of teratomas in many cases. So the amount 
of the transplanted hES cells in this study should be reduced 
than 5×104 to prevent tumor formation. The media-treated 
group received a 5μl culture medium injection into the 
epicenter of the injury. In order to prevent immune rejection, 
all rats received 10 mg/kg cyclosporine A (Sigma, Saint Louis, 
USA) daily from 2 days before the transplant.
5) Electrophysiological study after transplantation of 
hES cells
(1) Animal preparation: At 8 weeks after transplantation, 
the electrophysiological evaluation was performed including 
somatosensory evoked potentials (SSEP) and motor evoked 
potentials (MEP). The animals were anesthetized with urethan 
(Sigma, Saint Louis, USA) given by intraperitoneal injection 
(1.25 g/kg). Each animal was also given 0.8 mg/kg atropine 
sulfate (Sigma, Saint Louis, USA) to reduce tracheal secretions. 
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Using a surgical microscope, the right femoral artery and vein 
were catheterized and the trachea was intubated with 
tracheostomy. Pancuronium bromide 1 mg/kg (Sigma, Saint 
Louis, USA) was then perfused through the femoral vein to 
induce muscle relaxation. The rat was then artificially respirated 
using a small animal respirator (Model 683, Harvard Instru-
ments Inc., Holliston, USA) and expiratory CO2 was maintained 
within the physiological range using a capnometer (Model 2200, 
Traverse Medical Monitors, Saline, USA). Each animal was then 
placed on a stereotaxic device (Narishige Scientific Instrument 
Laboratory, Tokyo, Japan) and rectal temperature was main-
tained between 36.0 and 37.0°C using a feedback controlled 
heating blanket (Harvard Instruments Inc., Holliston, USA).
(2) Recording of somatosensory evoked potentials (SSEP): 
The left sciatic nerve was exposed and isolated. A pair of 
electrodes, a proximal cathode and a distal anode, was hooked 
around the nerve. A single square pulse of electrical stimulus 
was delivered by a stimulus isolator (A365D or A365, World 
Precision Instruments, New Haven, USA), which was driven by 
a pulse generator (Pulsemaster A300, World Precision Instru-
ments, New Haven, USA). The pulse duration of stimuli was 
0.1 msec and the intensity was 6 mA at 1∼4 Hz.
For the SSEP recording, craniectomy was performed in 
contralateral frontoparietal area. The exact area of craniectomy 
was 4 mm lateral to sagittal suture and 4 mm posterior to 
bregma. The special recording electrode (NE-120, Rhodes 
Medical Instruments, Woodland Hills, USA) was fixed on the 
sensorimotor cortex at 2 mm lateral to sagittal suture and 2 mm 
posterior to bregma. This electrode consisted of a round plate, 
which was 1.4 mm in diameter with a 0.2 mm shaft that was 
3 mm in length and protruded from the center of the plate. The 
electrode was insulated with the exception of the tip of the shaft 
(0.2 mm) and the bottom surface of the round plate. The 
pointed tip of the electrode with a 0.5 mm long exposed area 
was inserted into the cerebral cortex perpendicular to the 
cortical surface. This enabled gentle contact of the round flat 
surface with the cortical surface.
(3) Recording of motor evoked potentials (MEP): It was 
necessary to increase the area of stimulation in the motor cortex 
area in order to properly monitor the MEP with low stimulus 
intensity. For this purpose, the same special electrode which 
was already used for recording of the SSEP in this study was 
used. In cortical stimulation, the round area of the electrode was 
the anode and the pointed tip was the cathode. This electrode 
was designed to keep the cathode and the anode close together 
in order to prevent current spread. In addition, there was also 
a large enough surface for activating a large number of 
pyramidal neurons with a low intensity electrical current. 
Furthermore, the direction of current flow was designed to be 
the same as the projection of the pyramidal cell bodies. The 
sensorimotor cortex (2 mm lateral and 2 mm posterior to 
bregma), where the anode was placed, had almost flat geometry 
due to the rat having no sulci in the frontoparietal cortical area. 
The electrode was placed using a micromanipulator under 
microscopic guide, which enabled us to direct the cathode 
vertical to the cortical surface. A single square pulse (0.1 msec 
pulse duration and 6 mA intensity) of electrical stimulus was 
delivered by a stimulus isolator (A365D or A365, World 
Precision Instruments, New Haven, USA), which was driven by 
a pulse generator (Pulsemaster A300, World Precision Instru-
ments, New Haven, USA).
For MEP recording, laminectomy was performed at L1 
spinal level. The shape and specifications of recording elec-
trodes were the same as those of the stimulating electrodes. 
Following the laminectomy, the electrode was inserted into the 
contralateral gray matter of the spinal cord near the motor 
conduction tracts. The pointed tip of the electrode was used as 
an active electrode and the rounded part of the electrode was 
used as a reference electrode.
The analog signals of the evoked potential were amplified 
by AC amplifier (Model RPS 107, Grass Instrument Co., 
Warwick, USA), filtered (bandpass 1,000∼10,000 Hz), and 
averaged on an IBM-compatible personal computer system 
equipped with Spike 2 software (CED, Cambridge, UK). Each 
SSEP and MEP consisted of an average of 80∼100 single 
sweep epochs. In order to minimize the effect of anesthetics 
on the evoked potentials, recording commenced at least 20 
minutes after the injection of anesthetics.
The threshold of electrical stimulation was first determined 
in each experiment. The effect of the stimulation intensity was 
analyzed on the wave forms and latencies.
6) Histological examination
For the histological examination, the animals were anesthetized 
with pentobarbital (Sigma, Saint Louis, USA) and perfused 
transcardially with 150 ml of normal saline followed by 600 
ml of 4% paraformaldehyde (Sigma, Saint Louis, USA) in a 
0.1 M phosphate buffer 8 weeks after transplantation. The 
spinal cord was removed and stored in the same fixatives for 
2 hours and then processed for paraffin embedding or a 
cryosection.
For a pathological assessment, the spinal cords were subjected 
to paraffin embedding and Luxol fast blue-cresyl violet 
staining. The spinal cord sections were cut to an 8μm 
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Fig. 1. The Basso, Beattie and Bresnahan (BBB) scores of the spinal cord injured rats before and after transplantation. (A) BBB scores 
of the left leg. (B) BBB score of the right leg. Arrow (↓) indicates the transplantation point. The asterisks (*) indicate a statistically 
significant difference between the media-treated group ( ) and the hES cell-trasplanted groups (●, △) using an one-way ANOVA followed 
by Dunnet's multiple comparison test at each time point (*p＜0.05, †p＜ 0.01).
thickness, deparaffinized and incubated with 1% Luxol fast blue 
(Chameleon Chemical Reagent, Osaka, Japan) overnight, and 
differentiated with 0.05% lithium carbonate (Sigma, Saint 
Louis, USA). The sections were incubated with 0.1% cresyl 
violet (Sigma, Saint Louis, USA) for 6 minutes and rinsed with 
95% ethanol (Sigma, Saint Louis, USA), mounted and observed 
using an optical microscope (Olympus FV500, Olympus, 
Tokyo, Japan). 
The survival and differentiation of the transplanted hES cells 
into neuronal components were confirmed using double 
immunofluorescence for the human Tau protein, which is a 
class of microtubule associated proteins, and the glial fibrillary 
acidic protein (GFAP). Double labeling with the microtubule 
associated protein 2 (MAP2) and synaptophysin was also used 
to observe the neurons and terminals. The spinal cord tissues 
were dipped in sucrose for at least 24 hours, and 40μm-thick 
parasagittal sections were cut with a cryostat (CE, Walldorf, 
Germany). The sections were permeabilized with 50% ethanol 
for 30 minutes, blocked with 10% normal donkey serum (Life 
Technologies, Bochum, Germany) for 30 minutes, and incu-
bated overnight in a mixture of the primary antibodies; GFAP 
(Rabbit anti-cow-GFAP, 1：2000, DAKO, Glostrup, Denmark) 
and human Tau protein (mouse anti-human Tau protein, 1：100, 
Abcam, Cambridgeshire, UK) or MAP2 (mouse anti-MAP2, 
1：1000, Chemicon, Temecula, USA) and synaptophysin 
(rabbit anti-synaptophysin, 1：200, Zymed, South San Francisco, 
USA). The secondary antibodies (FITC- or Cy3-conjugated 
anti-rabbit or anti-mouse raised in donkey, 1：200, Jackson 
Immunoresearch, West Grove, USA) were applied for 3 hours. 
The sections were coverslipped and examined by confocal 
microscopy (Olympus FV500, Olympus, Tokyo, Japan). The 
double fluorescent images were saved in TIFF format, and the 
contrast and brightness were adjusted using the Adobe 
Photoshop software (v. 8, Adobe, San Jose, USA). The final 
plates were composed using Corel Draw (v. 10, Corel 
Corporation, Ontario, Canada).
One-way analysis of variance (ANOVA), followed by 
Dunnet's post-hoc multiple comparison test at each time point 
was conducted to evaluate the data obtained in the behavioral 
study. An independent t-test was also used to determine 
statistical differences between the media-treated and the hES 
cell-transplanted group for the electrophysiological study. A p 
value less than 0.05 was considered statistically significant.
RESULTS
1) Behavioral assessment 
The hind limb locomotor performance was tested in all the 
rats using the Basso, Beattie and Bresnahan (BBB) open-field 
scale.7 Prior to transplantation, the BBB tests were performed 
on all the animals at 1 day, 4 days, and 7 days after a SCI. 
The animals with a low score and equally malfunctioned hind 
limbs were selected for the experiments. The media-treated 
group (n=12) scored very low for both legs 1 day after the 
injury. The score gradually increased to 9 weeks after the injury 
(Fig. 1)(Table 1, 2). The 2×104 hES cell-transplanted group 
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Table 1. BBB Scores of the Left Leg in the SCI Rats
Days 
after SCI
Media-treated 
group
5×103 hES cell-
transplanted group
2×104 hES cell-
transplanted group
1 day
4 day
7 day
2 week
3 week
4 week
5 week
6 week
7 week
8 week
9 week
 0.44±0.12
 2.69±0.20
 6.70±0.25
 8.44±0.41
 8.83±0.55
 9.75±0.29
10.55±0.34
10.17±0.47
10.39±0.45
10.18±0.20
10.33±0.17
 0.69±0.17
 2.90±0.26
 6.85±0.26
 8.38±0.41
 8.97±0.55
10.44±0.34
10.92±0.36
 11.13±0.39*
10.96±0.34
10.55±0.17
10.73±0.25
0.66±0.22
2.83±0.21
7.18±0.28
8.96±0.50
9.73±0.39
10.20±0.18†
11.39±0.36*
11.67±0.53†
11.52±0.43†
10.70±0.58*
10.21±0.62*
Values were expressed as mean±standard deviation.
BBB: Basso, Beattie and Bresnahan, SCI: Spinal cord injured, 
hES: Human embryonic stem
*p＜0.05, †p＜0.01
Table 2. BBB Scores of the Right Leg in the SCI Rats
Days
after SCI
Media-treated 
group
5×103 hES cell-
transplanted group
2×104 hES cell-
transplanted group
1 day
4 day
7 day
2 week
3 week
4 week
5 week
6 week
7 week
8 week
9 week
 0.47±0.12
 2.85±0.19
 6.59±0.26
 8.31±0.36
 9.19±0.25
 9.79±0.30
10.45±0.40
 9.94±0.47
10.32±0.44
 9.90±0.19
10.22±0.15
 0.81±0.18
 3.13±0.26
 6.53±0.28
 8.27±0.40
 9.37±0.33
10.44±0.34
10.83±0.32
11.00±0.28
11.04±0.29
10.64±0.17
10.86±0.25
 0.74±0.21
 3.34±0.25
 7.10±0.28
 8.58±0.37
 9.40±0.65
10.30±0.18
11.43±0.37
 11.68±0.51*
 11.52±0.50*
10.65±0.52
10.43±0.48
Values were expressed as mean±standard deviation.
BBB: Basso, Beattie and Bresnahan, SCI: Spinal cord injured, 
hES: Human embryonic stem
*p＜0.05
(n=12) showed a significantly improved left (Fig. 1A)(Table 1) 
and right hind limb (Fig. 1B)(Table 2) performance after the 
transplant compared with the media-treated group (p＜0.05). 
However, the 5×103 hES cell-transplanted group (n=12) tended 
to show an increased hind limb performance after the transplant 
when compared with the media-treated group, but the difference 
was not significant except for the left hind limb at 5 weeks 
after transplantation. 
2) Electrophysiological study
At 8 weeks after transplantation, the electrophysiological 
evaluation, including somatosensory evoked potentials (SSEP) 
and motor evoked potentials (MEP), was performed in the 
media-treated group (n=33) and the 2×104 hES cell-transplanted 
group (n=29). However electrophysiological study was not 
performed in the 5×103 hES cell-transplanted group because 
there was no significant improvement of hind limb performance 
in the 5×103 hES cell-transplanted group, compared to the 
media-treated group, as mentioned above. In the media-treated 
group, the MEP and the SSEP recordings were detectable in 
16 and 28 rats respectively. And in the 2×104 hES cell- 
transplanted group, the MEP and the SSEP recordings were 
detectable in 16 and 21 rats respectively too. The responses of 
the MEP and the SSEP between the media-treated and the hES 
cell-transplanted group were analyzed using the chi-square test, 
but the between-group differences were not statistically signi-
ficant (p＞0.05).
Fig. 2A shows representative wave form of the SSEP, a 
negative-positive-negative potential (an upward deflection was 
designated as negative). The wave of the MEP had the same 
pattern as the SSEP too (Fig. 2B). However the MEP in the 
each group consisted of only a few peaks above the detection 
level of 1μv, on the other hand, the SSEP consisted of 
distinctive peaks with larger amplitudes than the MEP. The 
latencies of each evoked potential were measured from the 
onset of the initial rising phase from the baseline (Initial), the 
peak of the first negative deflection (N1) and the peak of the 
first positive deflection (P1). The amplitudes were measured 
also from the peak of the first negative deflection from the 
baseline (negative peak amplitude) and the distance between the 
peak of the first negative and positive deflection (peak to peak 
amplitude).
The initial and P1 latency of the MEP and the SSEP in the 
hES cell-transplanted group were significantly shortened when 
compared to the media-treated group (p＜0.05) (Fig. 3A, B) 
(Table 3, 4). In addition, the hES cell-transplanted group 
showed a significant increase in amplitudes of the MEP and 
the SSEP when compared with the media-treated group (p
＜0.05) (Fig. 3C, D)(Table 3, 4).
3) Histological examination and immunohistochemistry 
In the low power view of the spinal cord stained with Luxol 
fast blue and cresyl violet, the typical pathological findings of 
the SCI were observed in both the media- and hES cell- 
transplanted groups at 8 weeks after transplantation. However, 
the spinal cord of the media-treated group showed more 
extensive cavity formation, tissue necrosis, gliosis along the 
rostrocaudal extent and severe demyelination of the white 
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Table 4. Comparison in Results of the SSEP between the Media- 
treated and the 2×104 hES Cell-transplanted Group
SSEP
Media-treated 
group
2×104 hES cell-
transplanted group
Initial latency (msec)
N1 latency (msec)
P1 latency (msec)
Negative peak amplitude† 
(μv)
Peak to peak amplitude‡ 
(μv)
16.90±9.10
30.42±8.82
62.44±7.78
 2.49±0.54
 3.85±1.22
 13.18±9.43*
23.85±8.96
 48.71±7.23*
  5.91±1.22*
  8.26±1.83*
Values were expressed as mean±standard deviation.
SSEP: Somatosensory evoked potentials, hES: Human embryonic 
stem, Initial latency: Latency of the onset of the initial rising phase 
from the baseline, N1 latency: Negative peak latency, latency of 
the peak of the first negative deflection, P1 latency: Positive peak 
latency, latency of the peak of the first positive deflection
†: amplitude of the peak of the first negative deflection from the 
baseline, ‡: amplitude between the peak of the first negative and 
positive deflection
*p＜0.05
Fig. 2. Representative wave forms of evoked potentials recorded in the media-treated group and the human embryonic stem (hES) 
cell-transplanted group. (A) somatosensory evoked potentials (SSEP), (B) motor evoked potentials (MEP). Media: Media-treated group, 
TX-2: 2×104 hES cell-transplanted group.
Table 3. Comparison in Results of the MEP between the Media- 
treated and the 2×104 hES Cell-transplanted Group
MEP
Media-treated
group
2×104 hES cell-
transplanted group
Initial latency (msec)
N1 latency (msec)
P1 latency (msec)
Negative peak amplitude† 
(μv)
Peak to peak amplitude‡ 
(μv)
22.96±8.03
43.10±7.11
75.25±6.76
 0.26±0.06
 0.48±0.08
16.34±8.58*
37.58±8.41
62.41±7.21*
 0.70±0.10*
 0.90±0.10*
Values are expressed as mean±standard deviation.
MEP: Motor evoked potentials, hES: Human embryonic stem, 
Initial latency: Latency of the onset of the initial rising phase from 
the baseline, N1 latency: Negative peak latency, latency of the 
peak of the first negative deflection, P1 latency: Positive peak 
latency, latency of the peak of the first positive deflection
†: amplitude of the peak of the first negative deflection from the 
baseline, ‡: amplitude between the peak of the first negative and 
positive deflection
*p＜0.05
matter in the ventral funiculus (Fig. 4A, B). In the high power 
view of the dorsal horns in the vicinity of the necrotic cavity, 
necrotic cells, glial nuclei and inflammatory cells were 
predominant in the media-treated group. However, these 
pathological findings were significantly attenuated and there 
was no evidence of tumor formation in the hES cell-treated 
group (Fig. 4C, D). In double labeling immunohistochemistry 
for human Tau and GFAP, the glial scars heavily stained for 
GFAP were concentrated at the margin of the necrotic cavity. 
No Tau protein-positive cells were observed in the spinal cords 
of the media-treated group (Fig. 5A). On the other hand, in the 
spinal cord of the hES cell-treated group, a few cells positive 
for the Tau protein were scattered in the necrotic cavity, the 
spinal gray matter adjacent to the cavity, or in the white matter 
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Fig. 3. Electrophysiological changes in latencies and amplitudes after spinal cord injury and subsequent transplantation of human embryonic 
stem (hES) cells. Values are expressed as mean±standard deviation (msec, μV). (A) motor evoked potentials (MEP) latency, (B) 
somatosensory evoked potentials (SSEP) latency, (C) motor evoked potentials (MEP) amplitudes, (D) somatosensory evoked potentials 
(SSEP) amplitudes. Media: Media-treated group, TX-2: 2×104 hES cell-transplanted group, Initial: Latency of the onset of the initial rising 
phase from the baseline, N1: Latency of the peak of the first negative deflection, P1: Latency of the peak of the first positive deflection, 
N: Amplitude of the peak of the first negative deflection from the baseline, P: Amplitude between the peak of the first negative and 
positive deflection. The asterisks (*) indicate a statistically significant difference between the media-treated group and the hES cell- 
transplanted group using a student's t-test (*p＜0.05).
(Fig. 5B). These Tau-positive cells were round or ovoid-shaped, 
and the stain was in the cytoplasm, sparing the nuclei (Fig. 5C). 
In the double stain for MAP2 and synaptophysin, while most 
of the neurons were lost and the terminals were clumped in 
the media-treated rats (Fig. 5D), the anterior horn cells that 
were positive for MAP2 along with the surrounding terminals 
in the vicinity of the cavity were spared in the 2×104 hES 
cell-treated rats (Fig. 5E). In the margin of the cavity in the 
spinal cord of the hES cell-treated rats, cells with a strong 
immunoreaction for MAP2 were observed, and these cells were 
intermixed with varicosities positive for synaptophysin (Fig. 
5E, F).
DISCUSSION
Traumatic spinal cord injuries in animals give rise to lesions 
that are similar to those observed in human SCI. These animals 
show functional deficits after a SCI resulting from damage to 
the axons, the loss of neurons and glia, and demyelination.
The results in this study showed that a hES cell transplant 
significantly improved the locomotion recovery in animals with 
an acute SCI. In particular, the hind limb performance 
improved greatly in the 2×104 hES cell-transplanted group, 
compared with the media-treated group. To our knowledge, this 
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Fig. 4. Luxol fast blue cresyl violet stain of the spinal cords (parasagittal section) at 8 weeks after the transplantation of human embryonic 
stem (hES) cells. A and B: Low power view of the spinal cord of the media-treated (Media) and the 2×104 hES cell-transplanted (Cell) 
rat. Extensive tissue necrosis, glial scar formation (arrows) and demyelination (arrowheads) were observed in the spinal cord of the 
media-treated group, and these findings were attenuated in the spinal cords of the hES cell-transplanted group. The boxed areas (c, d) 
are magnified in C and D. C and D: High power view of the areas corresponding to the dorsal horn at the margin of the necrotic cavity. 
Neuronal necrosis and glial scar formation were predominant in the dorsal horn of the media-treated group (C) but these were not evident 
in that of the hES cell-transplanted group (D). Scale bars= 500μm.
is the first study to demonstrate the functional recovery after 
the transplantation of hES cells in spinal cord injured rats. 
Histologically, the transplantation also attenuated the demyeli-
nation and glial scar formation after the SCI. Some cells 
positive for the human Tau protein were observed 8 weeks after 
the transplant even though the number was not great. These 
results suggest that hES cells are effective in the functional 
recovery after being transplanted in spinal cord injured rats 
compared with the media-treated rats.
There have been a number of studies that have reported the 
improvement in the functional recovery after the transplantation 
in spinal cord injured animals. For example, Zurita and 
Vaquero8 reported a case of functional recovery in a chronic 
model using the transplantation of bone marrow stromal cells 
3 months after the SCI. They reported that the BBB score 
showed a significant increase at 4 weeks after the transplant. 
Similarly, it was previously shown that the hind limb per-
formance was significantly improved 28 days after transplanting 
oligodendrocyte precursor cells.9 In a related study, Groves et 
al.10 examined the ability of O-2A remyelination in a demyel-
inated spinal cord by an X-irradiation. It was shown that in rats, 
mouse embryonic stem cells differentiated into oligo-
dendrocytes, astrocytes and neurons, and the transplantation of 
mouse embryonic stem cells promoted the functional recovery 
after transplantation in spinal cord injured rats.3 Therefore, the 
transplantation of stem or precursor cells might be effective in 
the functional recovery after a SCI.
In the present study, a morphological study was performed 
to examine the survival and differentiation of the transplanted 
hES cells, which might contribute to the functional and 
morphological improvement. The results showed that the 
transplantation of hES cells attenuated glial scar formation and 
demyelination. This suggests that the functional improvement 
in this study might be due to the prevention of further 
degenerative changes or the facilitation of a self regeneration 
processes rather than to the neuronal differentiation of the 
transplanted cells. A glial scar is known to be a major cause 
of functional impairment after a SCI, where a functional deficit 
is largely due to an interruption in the long ascending and 
descending tracts rather than to the degeneration of the local 
neurons.11,12 The inhibition of the glial components, for 
example, proteoglycans, which implicate neuronal outgrowth, 
can promote the functional recovery after a SCI.13 The results 
of double labeling with MAP2 and synaptophysin showed that 
the neurons and synaptic terminals around the cavity were 
spared after transplantation. Recently, it was suggested that the 
host structures may benefit not only by the replacement of lost 
cells but also from the “chaperone” effect with neuroprotective 
substances expressed by stem cells.14 On the other hand, cells 
positive for the human Tau protein were observed in some 
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Fig. 5. Immunohistochemistry in the spinal cords 8 weeks after transplantation. A∼C: Confocal microscopy of the double 
immunofluorescence for glial fibrillary acidic protein (GFAP) and human Tau protein (Tau) in the spinal cord of the media-treated (Media) 
(A) and the 2×104 human embryonic stem (hES) cell-treated (Cell) rats (B and C) 8 week after transplantation. The cells positive for 
the human Tau proteins were scattered in the cavity and margin of the glial scar of the host spinal cord in the hES cell-treated rats 
(arrows in B). In the high power view, the Tau protein-positive cells (arrow in C) were round to ovoid in shape. D∼F: Double labeling 
for microtubule associated protein 2 (MAP2) and synaptophysin (Syn) in the spinal cord of the media-treated (D) and the 2×104 hES 
cell-treated (E and F) rats. In the media-treated group, the MAP2-positive neurons (arrowheads) were lost and the surrounding synaptic 
terminals were clumped in the vicinity of the cavity (D), but those were relatively spared in the hES cell-treated rats (E). In this animal, 
a number of cells at the margin of the cavity were strongly stained for MAP2 (arrows in E and F) and these cells were intermixed with 
the varicosities stained for synaptophysin (F). Scale bars= 100 μm in A, B, D, and E; 25μm in C; 10μm in F.
animals transplanted with 2×104 hES cells. However, only a 
small number of Tau-positive cells were observed in these 
animals, suggesting that the survival rate of the hES cells 
transplanted in the injured spinal cord was very low.
The possibility that the transplanted cells might also 
differentiate into neuroglial cells including oligodendrocytes, 
which play a critical role in remyelination, could not be 
excluded because the antibodies specific to glial cells of human 
origin was unavailable. Double labeling with human nuclear 
antigen (HNA) with other glial markers was attempted, but the 
antibody for HNA showed nonspecific binding to the de-
generating cells (data not shown).
In the electrophysiological evaluation of the present study, 
the latencies of motor and somatosensory evoked potentials in 
the transplanted rats were significantly shortened compared to 
the media-treated rats. In addition, the hES cell-transplanted 
group showed increased amplitudes when compared with the 
media-treated group. In 2001, Akiyama et al.2 examined the 
myelin repair potential of transplanted neural precursor cells 
derived from the adult human brain from tissue removed during 
surgery. They also suggested that transplantation of these cells 
into the demyelinated rat spinal cord resulted in extensive 
remyelination and the remyelinated axons conducted impulses 
at near normal latencies and conduction velocities. Recently, 
Bambakidis and Miller9 reported that MEP recordings revealed 
a strong trend towards significant improvement in the latencies 
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after transplanting oligodendrocyte precursors compared with 
controls. On the basis of such a prior studies, it seems quite 
likely that much of the electrophysiological findings in the 
present study can be explained by activity of the hES cell- 
derived oligodendrocytes in enhancing myelination or 
prevention of demyelination, rather than the replacement of lost 
neuron or axonal regeneration. This is consistent with the 
histological findings in this study.
Embryonic stem cells are derived directly from early 
embryos and are pluripotent, indicating that they are 
individually capable of giving rise to derivatives of each of the 
three primary germ layers and to germ cells. Embryonic stem 
cells retain the characteristics of the embryo founder cells, even 
after a prolonged culture and extensive manipulation.15 Because 
the cells can be cultured in vitro, there is a greater degree of 
control over their growth.16 In order to manipulate the cellular 
behavior, native or artificial factors can also be used. In 
addition, hES cells have been shown to differentiate into 
reasonable numbers of neural derivatives.17 Therefore, under 
these conditions, the transplantation of hES cells may be one 
of the promising cell replacement therapies for a human SCI. 
However further studies are necessary to identify the special 
stain for glial cells of human origin and quantify surviving and 
differentiated neural cells from the transplanted hES cells by 
cell counting. And additional long-term studies will be needed 
not only in animal models but in a human SCI.
CONCLUSION
This study showed that transplantation of hES cells into the 
injured rat spinal cord improved the hind limb weight support, 
shortened latencies and increased amplitudes of the evoked 
potentials and attenuated the glial scar formation and 
degenerative changes. In addition, some of the transplanted hES 
cells survived and differentiated into neurons. These results 
suggest that the transplantation of hES cells plays a role in 
promoting functional recovery after a SCI, and is one of the 
important candidates for future cell replacement therapies for 
a human SCI.
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